China News
Most Popular China Story
Teva to bulk up in Asia with generics buyouts
Now, it's Teva Pharmaceutical Industries ($TEVA) looking eastward for deals. The Israeli-based drugmaker figures the Asian generics market will be hopping over the next several years, with burgeoning Read more...
Latest Headlines
- February 8, 2012
- February 7, 2012
- February 7, 2012
- January 18, 2012
- January 12, 2012
- January 11, 2012
- December 21, 2011
- December 12, 2011
- December 8, 2011
- December 7, 2011
- December 6, 2011
- November 16, 2011
- November 11, 2011
- October 28, 2011
- October 10, 2011
- September 29, 2011
- September 16, 2011
- September 12, 2011
- August 12, 2011
- August 5, 2011
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
